SCHEMBL27745951

SCHEMBL27745951

O=CC1CN(c2cc3cc(CCCc4ccccc4)ccc3cc2O)S(=O)(=O)N1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.35
IGF1R P08069 1/20 0.34
ALOX15 P16050 1/20 0.34
CYP1A2 P05177 1/20 0.34
OPRK1 P41145 2/20 0.32
ADRB2 P07550 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
CHRM1 P11229 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
DRD1 P21728 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
ADRA1A P35348 1/20 0.32
PTGS2 P35354 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
PDE4D Q08499 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27758388 0.89 IGF1R (0.40) IGF1RALOX15OPRK1ADRB2ADORA3
SCHEMBL27725116 0.88 PTPN1 (0.37) PTPN1S1PR1
SCHEMBL27725115 0.87 GRIN2D (0.42) PTPN1
SCHEMBL27758479 0.87 IGF1R (0.43) IGF1RALOX15OPRK1ADRB2ADORA3
SCHEMBL27745967 0.86 PTPN1 (0.36) PTPN1CYP1A2SLC6A2SLC6A3
SCHEMBL27760075 0.85 PTPN1 (0.48) PTPN1IGF1RALOX15CYP1A2SLC6A2
SCHEMBL27745954 0.85 PTPN1 (0.38) PTPN1
SCHEMBL27725129 0.85 PTPN1 (0.40) PTPN1CYP1A2
SCHEMBL27760131 0.84 ADRB2 (0.36) PTPN1IGF1RALOX15OPRK1ADRB2
SCHEMBL27781668 0.84 PTPN1 (0.39) PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101326173-A Thiadiazoles derivant as anti-diabetes agent NOVARTIS AG (CH) 2008-12-17 CN claimed
CN-101883579-A Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders NOVARTIS AG 2010-11-10 CN disclosed
CN-101547694-A Protein tyrosine phosphatase inhibitors for promoting physiological cardiac hypertrophy NOVARTIS AG (CH) 2009-09-30 CN disclosed
CN-101326173-A Thiadiazoles derivant as anti-diabetes agent NOVARTIS AG (CH) 2008-12-17 CN disclosed